Recalibrating the risks and benefits of lithium therapy

14Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

Cite

CITATION STYLE

APA

Berk, M., Cowdery, S., Williams, L., & Malhi, G. S. (2017, July 1). Recalibrating the risks and benefits of lithium therapy. British Journal of Psychiatry. Royal College of Psychiatrists. https://doi.org/10.1192/bjp.bp.116.193789

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free